Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hightide Therapeutics Inc ( (HK:2511) ) has issued an announcement.
HighTide Therapeutics, Inc. has announced its upcoming Annual General Meeting to be held on June 27, 2025, in Hong Kong. The meeting will cover the adoption of financial statements, re-election of directors, and re-appointment of auditors. Additionally, resolutions will be discussed regarding the authorization of the board to issue additional shares, aiming to enhance the company’s operational flexibility and strategic positioning.
The most recent analyst rating on (HK:2511) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on Hightide Therapeutics Inc stock, see the HK:2511 Stock Forecast page.
More about Hightide Therapeutics Inc
HighTide Therapeutics, Inc. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on developing and providing therapeutic solutions, although specific products or market focus are not detailed in the release.
Average Trading Volume: 2,392,333
Technical Sentiment Signal: Buy
Current Market Cap: HK$1B
See more data about 2511 stock on TipRanks’ Stock Analysis page.